Literature DB >> 6870129

The treatment of recurrent pulmonary embolism: experience with the Kimray Greenfield vena cava filter.

J H Scurr, P E Jarrett, C Wastell.   

Abstract

Clinical experience with the Kimray Greenfield vena cava filter in 24 patients, most of whom suffered recurrent pulmonary embolism despite heparin treatment, is presented. The advantages of this filter over previous trans-venous filters is discussed. Initial results show the filter to be both safe and effective.

Entities:  

Mesh：

Year:  1983        PMID： 6870129      PMCID： PMC2494340     

Source DB:  PubMed          Journal:  Ann R Coll Surg Engl        ISSN： 0035-8843            Impact factor:   1.891


  6 in total

1.  The Mobin-Uddin umbrella filter in the management of proven and threatened pulmonary embolism.

Authors:  P A Dupont
Journal:  Ann R Coll Surg Engl       Date:  1976-07       Impact factor: 1.891

2.  Clinical experience with the Kim-Ray Greenfield vena caval filter.

Authors:  L J Greenfield; J Zocco; J Wilk; T M Schroeder; R C Elkins
Journal:  Ann Surg       Date:  1977-06       Impact factor: 12.969

3.  Inferior vena cava interuption: indications and results with caval ligation, clips and intracaval devices in 110 cases.

Authors:  E W Pollak; F C Sparks; W F Barker
Journal:  J Cardiovasc Surg (Torino)       Date:  1974 Nov-Dec       Impact factor: 1.888

4.  Comparative evaluation of ligation and partial interruption of the inferior vena cava.

Authors:  J T Adams; B E Feingold; J A DeWeese
Journal:  Arch Surg       Date:  1971-08

5.  A new intracaval filter permitting continued flow and resolution of emboli.

Authors:  L J Greenfield; J R McCurdy; P P Brown; R C Elkins
Journal:  Surgery       Date:  1973-04       Impact factor: 3.982

6.  Comparison of caval filters in the management of venous thromboembolism.

Authors:  M Wingerd; V M Bernhard; F Maddison; J B Towne
Journal:  Arch Surg       Date:  1978-11
  6 in total
  1 in total

1.  Management of a widowmaker.

Authors:  J W Peyton; E M McIlrath; J M Hood
Journal:  Ir J Med Sci       Date:  1984-05       Impact factor: 1.568
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.